Showing results (201-210 of 292) with videos related to
Sort By:
Pageof 30
NMR in Biomedicine|November 22, 2023
Uncovering prostate cancer aggressiveness signal in T2-weighted MRI through a three-reference tissues normalization techniqueAhmad Algohary, Evangelia I Zacharaki, Adrian L Breto, et al.International Journal of Radiation Oncology, Biology, Physics|March 24, 2025
Online Adaptive Radiation Therapy for Bladder Preservation: Transitioning to HypofractionationAnuradha Krishnan, Priyamvada Maitre, Sheetal Kashid, et al.Urologic Oncology|July 28, 2023
Surgical templates for inguinal lymph node dissection in cN0 penile cancer: A comparative studyGanesh K Bakshi, Mahendra Pal, Deep Kumar Jain, et al.Nuclear Medicine Communications|April 30, 2024
Can 18 F FDG PET/CT metabolic parameters be used to noninvasively differentiate between different histopathological subtypes and Fuhrman grades of renal cell cancer?Yash Jain, Archi Agrawal, Amit Joshi, et al.Cancers|November 14, 2023
Clinical-Genomic Risk Group Classification of Suspicious Lesions on Prostate Multiparametric-MRIRadka Stoyanova, Olmo Zavala-Romero, Deukwoo Kwon, et al.Bladder Cancer (Amsterdam, Netherlands)|February 3, 2017
The Rationale for Post-Operative Radiation in Localized Bladder CancerBrian C Baumann, Paul Sargos, Libni J Eapen, et al.International Journal of Radiation Oncology, Biology, Physics|March 30, 2025
PSMA-PET Guided Intraprostatic Boost in Prostate SBRT (PROBE): A Phase 2 TrialManeesh Singh, Aparna Katdare, Suchismita Ghosh, et al.Critical Reviews in Oncology/Hematology|January 19, 2025
« Augmented radiotherapy » in the management of high-risk prostate cancer (PCa): A systematic reviewJennifer Le Guévelou, Vedang Murthy, Thomas Zilli, et al.BMJ Open|March 2, 2020
Study protocol of a randomised controlled trial of prostate radiotherapy in high-risk and node-positive disease comparing moderate and extreme hypofractionation (PRIME TRIAL)Vedang Murthy, Indranil Mallick, Abhilash Gavarraju, et al.The Laryngoscope|March 15, 2021
Distress Screening in Head and Neck Cancer Patients Planned for Cancer-Directed RadiotherapyShirley Lewis, Saket Pandey, Naveen Salins, et al.Pageof 30